Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11158965rdf:typepubmed:Citationlld:pubmed
pubmed-article:11158965lifeskim:mentionsumls-concept:C0034705lld:lifeskim
pubmed-article:11158965lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:11158965lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:11158965lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:11158965pubmed:issue2lld:pubmed
pubmed-article:11158965pubmed:dateCreated2001-2-22lld:pubmed
pubmed-article:11158965pubmed:abstractTextWe investigated the possible contribution of inducible nitric oxide synthase (iNOS) to postischemic heart dysfunction and injuries in stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP, 13-14 wk of age, had significantly higher systolic blood pressure and greater heart weight than age-matched Wistar-Kyoto rats (WKY). Permanent occlusion of the left anterior descending coronary artery (LAD) caused significant and long-lasting increases in the activity and mRNA expression of myocardial iNOS in SHRSP compared with WKY. However, there was no significant difference in the LAD occlusion-induced expression of interleukin-1beta mRNA between SHRSP and WKY. Hemodynamic deterioration and myocardial fibrosis were also observed in SHRSP at 4 wk after LAD occlusion. Continuous administration of 2-amino-5,6-dihydro-6-methyl-4H-1,2-thiazin (AMT) completely blocked the LAD occlusion-induced increase in the myocardial iNOS activity of SHRSP. Moreover, postischemic heart dysfunction and injuries were also significantly ameliorated by 2-amino-5,6-dihydro-6-methyl-4H-1,2-thiazin (AMT). These results suggest that the increased activity of myocardial iNOS plays a pivotal role in the development of postischemic cardiac dysfunction and injuries in SHRSP with the hypertensive and hypertrophic heart.lld:pubmed
pubmed-article:11158965pubmed:languageenglld:pubmed
pubmed-article:11158965pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:citationSubsetIMlld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11158965pubmed:statusMEDLINElld:pubmed
pubmed-article:11158965pubmed:monthFeblld:pubmed
pubmed-article:11158965pubmed:issn0363-6135lld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:ItoTTlld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:AbeKKlld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:MuraeHHlld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:TakashimaAAlld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:IbiiNNlld:pubmed
pubmed-article:11158965pubmed:authorpubmed-author:TokumuraMMlld:pubmed
pubmed-article:11158965pubmed:issnTypePrintlld:pubmed
pubmed-article:11158965pubmed:volume280lld:pubmed
pubmed-article:11158965pubmed:ownerNLMlld:pubmed
pubmed-article:11158965pubmed:authorsCompleteYlld:pubmed
pubmed-article:11158965pubmed:paginationH668-73lld:pubmed
pubmed-article:11158965pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:meshHeadingpubmed-meshheading:11158965...lld:pubmed
pubmed-article:11158965pubmed:year2001lld:pubmed
pubmed-article:11158965pubmed:articleTitleInvolvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats.lld:pubmed
pubmed-article:11158965pubmed:affiliationDepartment of Drug Safety Evaluation, Developmental Research Laboratories, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825, Japan. kohji.abe@shionogi.co.jplld:pubmed
pubmed-article:11158965pubmed:publicationTypeJournal Articlelld:pubmed